Headquartered in Melville, NY, Henry Schein, Inc. (NASDAQ:HSIC) is a global leading provider of healthcare products and services. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Presently, Henry Schein serves more than 1 million customers and has operations in 32 countries. The company entered the prestigious Standard & Poor's (S&P) 500 Index in Mar, 2015.
Currently, Henry Schein has a Zacks Rank #3 (Hold) but that could change following its third quarter 2017 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.)We have highlighted some of the key details from the just-released announcement below:
Earnings: The Zacks Consensus Estimate is pegged at 90 cents per share. Henry Schein’s adjusted earnings per share of 87 cents missed this estimate by 3.33%.
Revenues: Henry Schein posted revenues of $3.16 billion, ahead of the Zacks Consensus Estimate for revenues of $3.05 billion.
Key Stats: Revenues in the third quarter derived from Henry Schein’s Dental segment grew 11.1% year over year to $1.48 billion, while Animal Health segment recorded sales of $882.6 million, up 11.7% compared with the prior-year quarter. Revenues from Medical segment increased 8% year over year to $690.8 million, while sales from Technology and Value-added services segment grew 4.1% to $109 million.
Henry Schein, Inc. Price and EPS Surprise
Major Factors: Per management, its four global segments gained solid market share during the quarter and delivered solid earnings growth on back of the strategy to grow the business organically and through acquisitions. The company decreased the higher end of the earlier provided range of $3.59-$3.65 of adjusted EPS guidance for 2017 to $3.59-$3.61.
Stock Price: Following the earnings release, share prices did not show any significant movement in the pre-market trading session.
Check back later for our full write up on this Henry Schein earnings report later!
Wall Street’s Next Amazon (NASDAQ:AMZN)
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>
Henry Schein, Inc. (HSIC): Free Stock Analysis Report
Original post